Bonus BioGroup Ltd. (BBIXF)

USD 0.02

(0.0%)

Market Cap (In USD)

23.35 Million

Revenue (In USD)

-

Net Income (In USD)

-28.52 Million

Avg. Volume

147.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.0E-4-0.055
PE
-
EPS
-
Beta Value
1.044
ISIN
IL0004850116
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Shai Meretzki Ph.D.
Employee Count
-
Website
https://www.bonusbiogroup.com
Ipo Date
2019-07-30
Details
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.